MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
In my May 2020 CW column, I introduced a new test method for measuring the fracture toughness within the facesheet-to-core interface region of sandwich composites. This proposed test method, referred ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
In this chapter, we focus on two topics: the lack of enforcement of existing U.S. Department of Defense (DOD) guidelines and procedures and the role of the program manager in the acquisition process.
This appendix presents a brief overview of the defense acquisition process. 1 The diagram below from the U.S. Department of Defense (2008:12 enclosure 2) depicts the development of defense systems as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results